Authors
Latest:
The proteome of proliferative vitreoretinopathy: insight into the central role of extracellular matrixStudy highlights extracellular matrix-related proteins expressed in PVR.
Latest:
Ophthalmology balances the promises and challenges of AISophisticated programs require an evolving mindset.
Latest:
ASCRS 2025: Seth Pantanelli, MD, speaks about compromise and decision-making in IOLsInvestigators were surprised by the outcome of a comparison between the Eyhance and enVista IOLs in low-light conditions.
Latest:
Electronic health records: Moving beyond 'just a requirement'Cutting-edge solutions are emerging in healthcare that streamline data capture through a user-friendly interface, leading to an increase in quality and accuracy of data collection while freeing physicians to spend more time with patients.
Latest:
Takeaway points from patient case #2Denise Visco, MD, MBA, discusses takeaway points from patient case #2 for post-operative inflammation management for routine cataract surgery.
Latest:
What ophthalmologists need to know about neuromyelitis optica spectrum disorderEarly diagnosis of NMOSD is key to preventing disability, improving survival.
Latest:
The future of decentralized clinical trials in ophthalmologyResearch can drive opportunities for patients with rare diseases
Latest:
Snowmass Retina and Eye 2025: Ronald Frenkel, MD, previews interactive learning and innovation amid winter funDr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, all set against the backdrop of Snowmass, Colorado.
Latest:
Unveiling genetic distinctions between reticular pseudodrusen and drusenInsights from a genome-wide association study identify novel genetic loci
Latest:
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MDRobert T. Chang, MD, from Stanford University discusses how large language models are transforming ophthalmology by enhancing patient communication, documentation, and education, while also addressing ethical considerations and potential future applications in glaucoma care.
Latest:
Patient Case #2 Initial ImpressionsBlake K Williamson MD, MPH, MS, discussed initial impressions of a female patient with high myopia and astigmatism who is an ideal candidate for phakic IOL implant.
Latest:
Pivotal study data drive glaucoma patient treatment decisionsTwo trials examine factors affecting the risk of disease.
Latest:
ARVO 2025: 8 year retrospective of DIMS spectacle lens in childrenAt ARVO 2025, in Salt Lake City, Utah, Carly Lam, PhD, MSc, and Tsz Wing Leung, PhD talked about the evaluation of the visual performance of 2 modified DIMS spectacle lens designs.
Latest:
Providing comprehensive eye care for diabetic patients in southern VietnamCommunity-based eye care is one of Orbis’s top priorities in the country.
Latest:
Final Thoughts on Case Presentations and Advanced TherapiesRetinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Latest:
Is office-based surgery a harbinger of things to come for ophthalmology?One practice’s experience with office-based surgery validates peer-reviewed study.
Latest:
Creating a positive patient financial journey for refractive error proceduresClear communication, transparent priceing, options are key to positive experience
Latest:
Quest continues for topical treatments for posterior segmentNovel treatments are now shifting paradigm in care of retinal diseases.
Latest:
Balancing Motherhood and Medicine: Navigating Maternity in OphthalmologyBalancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.
Latest:
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal DiseasesPanelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Latest:
Managing neovascular retinal disease in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key.
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
New and upcoming MIGS with Shan Lin, MDShan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers as they work to preserve vision and work towards a better future for glaucoma treatment options.
Latest:
Updated guidelines enhance choriocapillaris imaging in AMD with SS-OCTACompensation techniques in swept-source optical coherence tomography angiography improve accuracy by correcting signal loss from drusen and other artifacts
Latest:
ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgeryExploring how oral sedation and office-based surgery can enhance efficiency and patient experience
Latest:
Lessons from the Togo Glaucoma ProjectSLT shows promise as treatment for millions of Africans with glaucoma.
Latest:
ARVO 2025: The first phase 2 study to examine tyrosine kinase inhibitors for wet AMDKatherine Talcott, MD, a retina specialist at Cleveland Clinic, presented findings on EYP-1901 in the phase 2 DAVIO study.
